BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 27787359)

  • 1. Diagnostic Value of
    Lao TD; Truong PK; Le TAH
    Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer.
    Khatami F; Larijani B; Heshmat R; Keshtkar A; Mohammadamoli M; Teimoori-Toolabi L; Nasiri S; Tavangar SM
    PLoS One; 2017; 12(9):e0184892. PubMed ID: 28926589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High DAPK1 Expression Promotes Tumor Metastasis of Gastric Cancer.
    Wang Q; Weng S; Sun Y; Lin Y; Zhong W; Kwok HF; Lin Y
    Biology (Basel); 2022 Oct; 11(10):. PubMed ID: 36290392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of DAPK promoter methylation in lymphoma: A meta-analysis.
    Wang H; Zhou LY; Guan ZB; Zeng WB; Zhou LL; Liu YN; Pan XY
    PLoS One; 2019; 14(1):e0210943. PubMed ID: 30682070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of DAPK1 methylation and the risk of gastrointestinal cancer: A systematic review and meta-analysis.
    Yuan W; Chen J; Shu Y; Liu S; Wu L; Ji J; Liu Z; Tang Q; Zhou Z; Cheng Y; Jiang B; Shu X
    PLoS One; 2017; 12(9):e0184959. PubMed ID: 28934284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: A systematic meta-analysis (PRISMA).
    Lv X; Ye G; Zhang X; Huang T
    Medicine (Baltimore); 2017 Sep; 96(38):e8106. PubMed ID: 28930859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis.
    Dai L; Ma C; Zhang Z; Zeng S; Liu A; Tang S; Ren Q; Sun Y; Xu C
    PLoS One; 2016; 11(12):e0167228. PubMed ID: 27907054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of RARβ2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer: A PRISMA-compliant meta-analysis.
    Qi M; Xiong X
    Medicine (Baltimore); 2018 Dec; 97(51):e13666. PubMed ID: 30572486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effect of DAPK promoter methylation in gastric cancer: A systematic meta-analysis.
    Jia W; Yu T; Cao X; An Q; Yang H
    Medicine (Baltimore); 2016 Oct; 95(43):e5040. PubMed ID: 27787359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium.
    Nomura T; Tahara T; Shiroeda H; Minato T; Matsue Y; Hayashi R; Matsunaga K; Otsuka T; Nakamura M; Toshikuni N; Shibata T; Arisawa T
    BMC Gastroenterol; 2013 Jan; 13():1. PubMed ID: 23280118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death-associated protein kinase promoter methylation correlates with clinicopathological and prognostic features in nonsmall cell lung cancer patients: A cohort study.
    Yang XY; Zhang J; Yu XL; Zheng GF; Zhao F; Jia XJ
    J Cancer Res Ther; 2018; 14(Supplement):S65-S71. PubMed ID: 29578152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DAPK promoter methylation status correlates with tumor metastasis and poor prognosis in patients with non-small cell lung cancer.
    Zhang J; Yu XL; Zheng GF; Zhao F
    Cancer Biomark; 2015; 15(5):609-17. PubMed ID: 26406950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of death-associated protein kinase expression in primary gastric cancers from Chinese patients.
    Ye M; Li D; Zhou F; Guo Q; Xia B
    Eur J Cancer Prev; 2012 May; 21(3):241-6. PubMed ID: 21979297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between promoter methylation of DAPK gene and HNSCC: A meta-analysis.
    Cai F; Xiao X; Niu X; Zhong Y
    PLoS One; 2017; 12(3):e0173194. PubMed ID: 28249042
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.